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Associations of creatinine/
cystatin C ratio and postoperative 
pulmonary complications in elderly 
patients undergoing off‑pump 
coronary artery bypass surgery: 
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Sarcopenia along with nutritional status are associated with postoperative pulmonary complications 
in various surgical fields. Recently, the creatinine/cystatin C ratio and CONtrolling NUTritional status 
score were introduced as biochemical indicators for sarcopenia and malnutrition, respectively. 
We aimed to investigate the associations among these indicators and postoperative pulmonary 
complications in elderly patients undergoing off‑pump coronary artery bypass surgery. We reviewed 
the medical records of 605 elderly patients (aged ≥ 65 years) who underwent off‑pump coronary 
artery bypass surgery from January 2010 to December 2019. Postoperative pulmonary complications 
(pneumonia, prolonged ventilation [> 24 h], and reintubation during post‑surgical hospitalisation) 
occurred in 80 patients. A 10‑unit increase of creatinine/cystatin C ratio was associated with a reduced 
risk of postoperative pulmonary complications (odds ratio: 0.80, 95% confidence interval: 0.69–0.92, 
P = 0.001); the optimal cut‑off values for predicting postoperative pulmonary complications was 89.5. 
Multivariable logistic regression analysis revealed that age, congestive heart failure, and creatinine/
cystatin C ratio < 89.5 (odds ratio 2.36, 95% confidence interval 1.28–4.37) were independently 
associated with the occurrence of postoperative pulmonary complications, whereas CONtrolling 
NUTritional status score was not. A low creatinine/cystatin C ratio was associated with an increased 
risk of developing postoperative pulmonary complications after off‑pump coronary artery bypass 
surgery.
Confronting the challenges of an aging society, the prognostic importance of sarcopenia along with malnutrition 
has been highlighted as core concept of frailty because they are potentially modifiable factors that may improve 
outcomes in older adult patients requiring  surgery1. Sarcopenia, which manifests as low muscle strength with low 
muscle quantity or quality, is observed in 25–60% of patients undergoing major  surgeries1–3. While computed 
tomography (CT) and magnetic resonance imaging (MRI) are the gold standard techniques for the measurement 
of muscle  quantity4, they may not be readily feasible for general use in terms of accessibility and socioeconomic 
 efficiency5. In this context, the creatinine/cystatin C (CysC) ratio, a recently introduced objective biochemical 
sarcopenia  indicator5, may be considered as a practical alternative.
Both serum creatinine and CysC levels reflect glomerular filtration rate based on muscle and nucleated cells, 
 respectively6, indicating that the creatinine/CysC ratio potentially reflects muscle mass. The creatinine/CysC ratio 
has shown a strong association with CT-assessed muscle quantity in patients with cancer (no disclosure of the 
specific correlation method; Pearson’s or Spearman’s r = 0.648, P < 0.001), critically ill status (Pearson’s r = 0.62, 
P < 0.001), and lung transplant surgery (Pearson’s r = 0.43, P = 0.02)5,7,8. Additionally, a statistically significant 
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correlation with muscle strength derived from a handgrip test (Spearman’s r = 0.54, P < 0.01) and a good perfor-
mance on discriminating sarcopenia (AUROC = 0.87) in patients with chronic obstructive pulmonary disease 
have been  reported9.
Among the complications related to sarcopenia, postoperative pulmonary complications (PPCs) are common 
after cardiac surgery; this complication is often associated with detrimental  prognosis10,11. Despite a seemingly 
beneficial effect on the lungs by avoiding cardiopulmonary bypass, off-pump coronary artery bypass surgery 
(OPCAB) continues to be associated with a high prevalence of PPCs, ranging from 3.1 to 11.4%12–14. Thus, 
the identification of objective and modifiable preoperative risk factors, such as sarcopenia, for PPCs in older 
adult patients undergoing OPCAB would be of clinical significance to improve postoperative recovery through 
early rehabilitation. In addition, malnutrition, a factor closely related to sarcopenia, has been defined by an 
objective biochemical nutritional index, CONtrolling NUTritional status (CONUT)  score15. It, too, has been 
associated with PPCs and survival in patients undergoing cancer  resection16,17. The CONUT scoring includes an 
immune indicator (total lymphocyte count), a caloric depletion parameter (cholesterol), and traditional serum 
protein markers (albumin concentration). In addition to the nutritional status, CONUT score also reflects the 
patient’s immunologic  status15, both of which could be closely interlinked with PPCs. Despite the interrelation-
ship between sarcopenia, malnutrition, and PPCs, limited evidence is available on the relevance of the objec-
tive indices (creatinine/CysC ratio and CONUT score, respectively) and occurrence of PPCs in older patients 
undergoing OPCAB.
In this retrospective, single-centre study, we investigated the associations between the creatinine/CysC ratio 
and CONUT score and PPCs (primary outcomes) and other morbidities/mortality outcomes (secondary out-
comes) in older patients undergoing OPCAB.
Methods
Patients. The institutional review board of Severance Hospital, Seoul, South Korea (IRB no. 4-2020-1128 on 
November 26, 2020) approved this study and waived the requirement for written informed consent. This study 
was registered at ClinicalTrials.gov (NCT04654663; first posted: December 4, 2020) and conducted according 
to the 2013 Declaration of Helsinki. This manuscript adheres to the Strengthening the Reporting of Observa-
tional Studies in Epidemiology guidelines. Data were retrospectively collected from electronic medical records 
of patients who underwent OPCAB at the Severance Cardiovascular Hospital, Yonsei University Health System, 
Seoul, Korea, from January 2010 to December 2019.
Patients aged ≥ 65 years with serum CysC and creatinine test results obtained within 1 week before surgery 
were enrolled. Patients with chronic kidney disease (estimated glomerular filtration rate < 60 mL  min−1 1.73  m−2), 
acute kidney injury, or respiratory tract infection requiring medical therapy that occurred within 1 month before 
surgery were excluded. Definition of acute kidney injury was based on the Kidney Disease: Improving Global 
Outcomes  criteria18.
Data collection. All operations were performed by two expert surgeons (Y.K.J. and Y.Y.N.) with an experi-
ence of > 100 surgeries. All data were extracted from the patients’ electronic medical charts and prospectively 
recorded protocol forms. The baseline patient demographic data included age, sex, height, weight, Body mass 
index (BMI), nature of the operation (emergency operation and/or reoperation), EuroSCORE II, smoking status, 
and history of hypertension, diabetes mellitus, cerebrovascular disease, congestive heart failure, chronic obstruc-
tive pulmonary disease, and myocardial infarction within 1 month before surgery. Preoperative serum creati-
nine, CysC, albumin, cholesterol, C-reactive protein, and blood haemoglobin levels and lymphocyte count were 
also recorded. The CONUT score was calculated based on Ulíbarri’s  study15. A CONUT score of < 5 (normal or 
light undernutrition) was regarded as a low CONUT grade, whereas a CONUT score of ≥ 5 (moderate-to-severe 
undernutrition) was regarded as a high CONUT grade. Anaemia was defined as a haemoglobin level < 12.0 g/
dL for women and < 13.0 g/dL for men, according to the World Health Organization guidelines. The estimated 
glomerular filtration rate was calculated from patient serum creatinine levels using the chronic kidney dis-
ease epidemiology collaboration  equation19. Additionally, the presence of significant (> 50%) left main coronary 
stenosis on coronary angiography and moderate or higher mitral regurgitation grades on preoperative echo-
cardiography and use of preoperatively administered medications (aspirin, clopidogrel, beta-blockers, calcium 
channel blockers, renin-angiotensin system antagonists, insulin, and 3-hydroxy-3-methylglutaryl coenzyme A 
reductase inhibitors) were recorded.
The intraoperative and postoperative data (for 24 h after the operation), including the number of grafts 
anastomosed, duration of operation/anaesthesia, fluid and transfusion requirement, amount of cell saver infu-
sion, and urine output and chest tube drainage, were assessed. Intensive care unit (ICU) and hospital stay length 
and major post-surgical complications (pneumonia, prolonged ventilation [> 24 h], reintubation, renal failure, 
delirium, reoperation due to bleeding/tamponade, permanent stroke, and mortality) were also evaluated. All 
complications, except pneumonia, were defined based on the STS Adult Cardiac Surgery Database Data Specifica-
tions version 4.20.220; pneumonia followed the definition of the European Perioperative Clinical  Outcome21. All 
complications, except for mortality, were limited to the occurrence of an event during hospitalisation for surgery. 
Mortality included events occurring after hospital discharge through the end of the thirtieth postoperative  day20.
Study endpoint. The primary endpoints were the association of the creatinine/CysC ratio and CONUT 
score with PPCs (pneumonia, prolonged ventilation [> 24 h], and reintubation).
The secondary endpoints were the association of the indices with morbidity endpoints (renal failure, delirium, 
reoperation due to bleeding/tamponade, permanent stroke, and mortality).
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Statistical analyses. Patients were divided into two groups based on the occurrence of PPCs. To make 
intergroup comparisons, the continuous variables were analysed using an independent t-test or Mann–Whitney 
U test based on the results of a Shapiro–Wilk normality test. Categorical variables were analysed using a Chi-
squared test or Fisher’s exact test. Binary data were presented as numbers (%), whereas continuous data were 
presented as either a mean ± standard deviation or median (interquartile range) based on the distribution.
A binary logistic regression analysis was performed, with or without adjusting for the EuroSCORE II, to 
determine the association between the creatinine/CysC ratio and morbidity endpoints. The area under the 
receiver operating characteristic curve (AUROC) was also calculated. By maximising the Youden index, the 
optimal cut-off value was determined and utilised for classifying the high and low creatinine/CysC ratio groups.
Age, sex, potential risk factors (P value < 0.05 in the univariable analysis), CONUT grade, and the creatinine/
CysC ratio (either continuous or binary variables with a cut-off value of 89.5) were included in the multivariable 
binary logistic model for the occurrence of PPCs. The rule of ten was applied to each model to avoid overfitting, 
and the model with the highest concordance statistics was selected. The statistical significance was set at a P 
value of < 0.05.
All analyses were performed using SPSS version 25 software (IBM Corp., Armonk, NY, USA), R version 4.0.2 
(The R Foundation for Statistical Computing, Vienna, Austria), and SAS (version 9.4, SAS Inc., Cary, NC, USA).
Results
We initially screened 2104 patients who underwent OPCAB between 2010 and 2019. Among them, 1383 patients 
were excluded, and finally, 605 patients were enrolled (Fig. 1). No data regarding the outcome endpoints were 
missing. In other variables, except for intraoperative blood loss (189 missing data) and the amount of cell saver 
infusion (18 missing data), there were none or less than 10 data missing occurred. Missing data were excluded 
from analyses.
A total of 80 (13.2%) patients experienced PPCs. Patients in the PPC group showed a statistically signifi-
cant lower creatinine/CysC ratio than did those in the non-PPC group (80.6 ± 16.5 vs 87.5 ± 18.2, P = 0.001). 
Patients in the PPC group were older with lower BMI, higher EuroSCORE II, and CONUT score and were more 
likely to undergo emergent OPCAB than patients in the non-PPC group were. In the PPC group, patients were 
more frequently diagnosed with anaemia and congestive heart failure than those in the non-PPC group were 
(Table 1). Preoperative laboratory data demonstrated a lower serum albumin concentration in the PPC group 
(3.8 ± 0.5 g  dL−1 vs. 4.0 ± 0.4 g  dL−1, P = 0.001) than in the non-PPC group (Supplementary Table S1).
Intra- and post-operative data, including fluid balance, were comparable between the PPC and non-PPC 
groups (Table 2).
The odds ratio of creatinine/CysC ratio per 10 units for the occurrence of postoperative morbidity endpoints 
is presented in Table 3. A 10-unit increase of creatinine/CysC ratio (continuous variable) was associated with 
a reduced risk of PPC occurrence with (odds ratio: 0.82, 95% confidence interval [CI]: 0.72–0.95, P = 0.010) or 
without adjustments (odds ratio: 0.80, 95% CI: 0.69–0.92, P = 0.001) for EuroSCORE II. Additionally, permanent 
stroke was negatively associated with creatinine/CysC ratio) (per 10 units) after adjustments for EuroSCORE 
II (odds ratio: 0.45, 95% CI: 0.21–0.95, P = 0.036). An increase of one unit of creatinine/CysC ratio was associ-
ated with decreased ICU and hospital stay lengths (regression coefficient: − 0.035, 95% CI: − 0.0526 to − 0.0174, 
P = 0.0002 and regression coefficient: − 0.122, 95% CI: − 0.1690 to − 0.0770, P < 0.0001, respectively).
The optimal cut-off values for predicting PPCs were 89.5 (sensitivity, 77.5%; specificity, 45.5%; AUROC, 
0.615) for both sexes—90.5 (sensitivity, 76.4%; specificity, 56.8%) for males and 71.7 (sensitivity, 64.0%; speci-
ficity, 51.8%) for females. Patients with a low creatinine/CysC ratio were older and more frequently women 
than patients with a high creatinine/CysC ratio were; they also had a greater incidence of emergent operation, 
congestive heart failure, moderate or higher mitral regurgitation, and lower haemoglobin, lower albumin, and 
higher C-reactive protein levels than patients with a high creatinine/CysC ratio did (Supplementary Table S2). 
A low creatinine/CysC ratio was associated with not only an increased risk of PPC occurrence but also an 
increased risk of renal failure and mortality. This association continued even after adjustment for EurSCORE II 
(Supplementary Table S3).
Patients with a high CONUT grade had a lower BMI, higher EuroSCORE II, greater incidence of cerebro-
vascular accident, myocardial infarction within within 1 month, and anaemia, lower creatinine/CysC ratio, and 
higher C-reactive protein levels than those with a low CONUT grade did (Supplementary Table S4). A high 
CONUT grade was associated with an increased risk of PPC and delirium (Supplementary Table S5).
In the multivariable model for identifying risk factors for PPCs, low creatinine/CysC ratio was found to be 
an independent risk factor (odds ratio: 2.36, 95% CI: 1.28–4.34, P = 0.006), whereas an increase in ten units of 
creatinine/CysC ratio was not independently associated with the occurrence of PPCs (odds ratio: 0.84, 95% CI: 
0.71–1.01, P = 0.060). Unlike the CONUT score ≥ 5, age and congestive heart failure were independently associ-
ated with the occurrence of PPCs (Table 4).
Discussion
In our retrospective study, a creatinine/CysC ratio of < 89.5, a surrogate marker for sarcopenia, was independently 
associated with occurrence of PPCs in older adult patients who underwent OPCAB along with age and conges-
tive heart failure, whereas the CONUT score was not. Additionally, a low creatinine/CysC ratio was related to 
an increased risk of permanent stroke, renal failure, mortality, and prolonged ICU/hospital stays after surgery.
The prevalence of PPCs after cardiac surgery is 27–35%10,22,23. In multivessel OPCAB, median sternotomy, 
internal mammary artery dissection, and lung manipulation are still necessary, resulting in direct lung injury and 
severe  pain10. Thus, despite avoiding cardiopulmonary bypass, PPC remains one of the leading complications after 
OPCAB, which further progresses to other morbidities or  death10. If a correctible vulnerable target is detected in 
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advance, followed by preventive or patients-specific care, it is expected to enhance recovery and reduce socio-
economic  costs24. Preoperative sarcopenia has been associated with PPCs in cancer  cohorts1,25. Sarcopenia is 
closely related to dysphagia and respiratory muscle  weakness26, and it is observed at a high frequency in patients 
with respiratory  failure27. Likewise, an increased incidence of community-acquired pneumonia was reported in 
older patients with  sarcopenia28. Moreover, low muscle mass may imply impaired immunity or  inflammation3, 
which also enhances the risk of PPCs.
The recently proposed creatinine/CysC ratio is easily obtained with a simple calculation using serum cre-
atinine and CysC  levels5. Since serum creatinine originates from muscle catabolism and CysC is produced by 
nucleated  cells6, a low creatinine/CysC ratio implies low muscle mass and, thus, sarcopenia. In our study, low 
creatinine/CysC ratio, as a binary variable (< 89.5) implying sarcopenia, was independently associated with PPCs 
after OPCAB, while creatinine/CysC ratio, as a continuous variable, only showed an association with PPCs in 
the univariable analysis. Binary instead of a linear value appeared to be a more meaningful parameter for the 
occurrence of PPC. In other words, knowing whether the muscle is normal or sarcopenic is more important 
than knowing the absolute value of the muscle mass; if the muscle mass is within the normal range, an increase 
in it might not reduce the risk of PPCs. In agreement with our results, previous studies using CT for diagnos-
ing sarcopenia that implemented a binary approach showed an association between sarcopenia and pulmonary 
morbidity in critically ill  patients29,30 and surgical patients with colon and oesophageal  cancers1,31. Some of these 
studies examined the linear relationship between muscle mass and pulmonary morbidity; however, the results 
were  inconsistent29,30, showing a weak linear relationship.
Figure 1.  Flow chart of patient enrolment. Among the 2104 patients scheduled for off-pump coronary artery 
bypass graft surgery from January 2010 to December 2019, 1383 did not meet the inclusion criteria (1059 
patients were < 65 years old, and 324 did not have serum cystatin C and creatinine test results that were obtained 
within 1 week before surgery). Among the remaining 721 patients, 116 met the exclusion criteria (86 patients 
had chronic renal failure, 13 had acute kidney injuries, and 17 had respiratory tract infections within 1 month 
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Table 1.  Baseline patient characteristics. Values are presented as mean ± standard deviation, median 
[interquartile range], or the number of patients (percent). The CONtrolling NUTritional status score is 
expressed as median (range). BMI, body mass index; PPC, postoperative pulmonary complication; RAS, renin-
angiotensin system; CHF, congestive heart failure; CVA, cerebrovascular accident; COPD, chronic obstructive 





(n = 525) P value
Age (years) 73.4 ± 4.3 71.5 ± 4.4  < 0.001
Male sex 55 (68.8) 384 (73.1) 0.412
Emergency 5 (6.3) 10 (1.9) 0.037
BMI (kg/m2) 23.5 [20.7–25.1] 24.0 [22.3–25.9] 0.004
EuroSCORE II 1.36 [1.13–1.84] 1.18 [0.94–1.57] 0.001
Current smoker 11 (13.8) 68 (13.0) 0.844
Hypertension 64 (80.0) 395 (75.2) 0.354
Diabetes mellitus 39 (48.8) 264 (50.3) 0.798
CVA 13 (16.3) 67 (12.8) 0.391
CHF 17 (21.3) 42 (8.0)  < 0.001
COPD 5 (6.3) 25 (4.8) 0.578
MI within 1 month 29 (36.3) 153 (29.1) 0.197
Left main > 50% stenosis 23 (28.7) 152 (29.0) 0.970
Mitral regurgitation ≥ moderate 7 (8.8) 25 (4.8) 0.174
Preoperative medications
Aspirin 69 (86.3) 451 (85.9) 0.934
Clopidogrel 50 (62.5) 299 (57.0) 0.349
Beta-blocker 39 (48.8) 297 (56.6) 0.190
Calcium channel blocker 36 (45.0) 221 (42.1) 0.624
RAS inhibitor 44 (55.0) 300 (57.1) 0.718
Insulin 5 (6.3) 46 (8.8) 0.451
HMG-CoA reductase inhibitors 63 (78.8) 420 (80.0) 0.795
Reoperation 1 (1.3) 4 (0.8) 0.509
Anaemia 45 (56.3) 223 (42.5) 0.021
CONUT 2 (0–8) 2 (0–11) 0.020
Creatinine/cystatin C ratio 80.6 ± 16.5 87.5 ± 18.2 0.001
Table 2.  Intra- and post-operative data. Values are presented as means ± standard deviations, medians 
[interquartile ranges], or the number of patients (percentages). PPC, postoperative pulmonary complication; 





(n = 525) P value
Intraoperative data
Graft number 3 [3–4] 3 [3–4] 0.816
Duration of anaesthesia (mins) 298 [270–333] 300 [275–325] 0.761
Duration of operation (mins) 225 [200–252] 228 [205–250] 0.720
Total fluid input (mL) 2443 ± 753 2318 ± 845 0.215
Urine output (mL) 240 [135–403] 280 [150–475] 0.097
Blood loss (mL) 530 [370–740] 610 [480–790] 0.074
Cell saver infusion (mL) 219 [130–245] 220 [170–270] 0.139
Number of patients who had pRBC transfused 23 (28.7) 112 (21.3) 0.138
Number of patients who had blood transfused 24 (30.0) 129 (24.6) 0.298
Postoperative data for 24 h
Total fluid input (mL) 3730 [3155–4210] 3736 [3269–4290] 0.722
Urine output (mL) 2550 [2035–3090] 2670 [2085–3200] 0.404
Chest tube drainage (mL) 720 [495–880] 700 [530–870] 0.796
Number of patients who had pRBC transfused 26 (32.5) 144 (27.4) 0.347
Number of patients who had blood transfused 35 (43.8) 204 (38.9) 0.404
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Additionally, in our study, low creatinine/CysC ratio was associated with not only PPCs but also with other 
morbidity endpoints, such as permanent stroke, renal failure, mortality, and longer ICU and hospital stay lengths, 
implicating a more generalised effect in terms of outcome. Similarly, a correlation has been reported between low 
creatinine/CysC ratio and poor prognosis in critically ill  patients5,32,33. In a retrospective study of 226 critically 
ill patients (stable kidney disease), a subgroup analysis involving patients on invasive mechanical ventilators 
(n = 131) revealed an association between higher creatinine/CysC ratio and shorter duration of mechanical 
 ventilation5. In another retrospective study involving neurocritically ill patients (n = 538, with stable kidney 
function), the creatinine/CysC ratio was significantly correlated with the duration of mechanical ventilation, risk 
of tracheostomy, and length of neurocritical care  unit33. A recent study in older adult patients who underwent 
percutaneous coronary intervention demonstrated that a low creatinine/CysC ratio increased the risk of major 
adverse cardiovascular events and  mortality34. As a primary site of glucose uptake and protein reservoir, skeletal 
muscle supplies fuel and ingredients for the body to function and to  recover35. Thus, sarcopenia indicates a lack of 
reserve for coping with external stress; it could be related to poor prognosis in critically ill and surgical  patients3–5.
In contrast to our expectation, the CONUT score was not independently associated with PPC in our study. 
In terms of causality, sarcopenia takes a long time to develop. It is affected not only by malnutrition but also by 
various factors, such as physical inactivity and  comorbidities36. In a study on patients with respiratory failure 
requiring mechanical  ventilation27, a significant number of patients classified as normally nourished were found 
to be sarcopenic. Muscle is an important protein storehouse during fasting or stressful  conditions37. Surgery 
intensifies a patient’s catabolic status, increasing protein demand beyond the amount supplied by the  diet38; 
therefore, the muscle mass is more clinically relevant as a nutritional reserve during the perioperative period. 
Our results imply that a low creatinine/CysC ratio is more appropriate than the CONUT score for selecting 
OPCAB patients vulnerable to PPCs. For these patients, preoperative physiotherapy, and protein supplementa-
tion to correct sarcopenia might be effective interventions for preventing the occurrence of  PPCs35,39,40, although 
verification through further research is needed.
Our study has several strengths. Since the creatinine/CysC ratio, an easily acquired and objective indicator, 
is not influenced by the operator, it can be utilised as a screening test. Moreover, it can be applied to various 
Table 3.  Odds ratio for the creatinine/cystatin C ratio per 10 units (continuous variable) for the occurrence of 
postoperative complications. a Adjusted by EuroSCORE II. OR, odds ratio; CI, confidence interval.
Outcomes
Unadjusted OR
(95% CI) P value
aAdjusted OR
(95% CI) P value
Pulmonary complications 0.80 (0.69–0.92) 0.001 0.82 (0.72–0.95) 0.010
Pneumonia 0.74 (0.59–0.92) 0.008 0.75 (0.60–0.94) 0.013
Prolonged ventilation 0.83 (0.72–0.97) 0.021 0.87 (0.74–1.02) 0.087
Reintubation 0.73 (0.56–0.93) 0.012 0.75 (0.58–0.97) 0.030
Renal failure 0.74 (0.55–1.01) 0.057 0.75 (0.55–1.03) 0.072
Delirium 0.89 (0.79–1.00) 0.057 0.92 (0.81–1.03) 0.144
Reoperation due to bleeding/tamponade 1.11 (0.82–1.49) 0.501 1.10 (0.81–1.49) 0.539
Permanent stroke 0.49 (0.24–1.03) 0.061 0.45 (0.21–0.95) 0.036
Mortality 0.79 (0.59–1.06) 0.109 0.81 (0.61–1.09) 0.173
Table 4.  Univariable and multivariable analysis for postoperative pulmonary complications. OR, odds ratio; 
CI, confidence interval; BMI, body mass index; CONUT, CONtrolling NUTritional status; CHF, congestive 





OR (95% CI) P value OR (95% CI) P value
Age (years) 1.10 (1.05–1.16)  < 0.001 Age (years) 1.07 (1.01–1.13) 0.016
Male sex 1.24 (0.74–2.06) 0.413 Male sex 0.88 (0.49–1.56) 0.655
BMI (kg/m2) 0.89 (0.82–0.97) 0.005 BMI (kg/m2) 0.93 (0.85–1.01) 0.078
Current smoker 1.07 (0.54–2.13) 0.844
Emergency 3.43 (1.14–10.32) 0.028 Emergency 2.45 (0.77–7.76) 0.128
CHF 3.10 (1.67–5.78)  < 0.001 CHF 2.62 (1.35–5.06) 0.004
COPD 1.33 (0.50–3.59) 0.569
Reoperation 1.65 (0.18–14.94) 0.657
Anaemia 1.74 (1.08–7.80) 0.022 Anaemia 1.43 (0.85–2.39) 0.176
CONUT score ≥ 5 2.59 (1.28–5.26) 0.008 CONUT score ≥ 5 1.67 (0.77–3.66) 0.196
Creatinine/cystatin C ratio < 89.5 2.88 (1.66–5.00)  < 0.001 Creatinine/cystatin C ratio < 89.5 2.36 (1.28–4.34) 0.006
Creatinine/cystatin C ratio (per 10 units) 0.80 (0.69–0.92) 0.001 Concordance statistics 0.720
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patient groups (neurocognitive impaired patients, bed-ridden patients, and patients with unstable vital signs) 
and in various clinical situations (emergent operation and critical care unit), as it does not require patient effort 
or cooperation or any shift in the position. We are the first to analyse the effect of creatinine/CysC ratio on the 
occurrence of PPCs in patients undergoing OPCAB. Despite the disadvantage of being a retrospective study, 
there were no missing data related to the primary outcomes, and several possible confounding factors were 
controlled in the analysis.
However, our study had some limitations. First, in addition to the inherent limitations of a retrospective 
study, muscle quality or strength was not measured in our study. Although creatinine/CysC ratio has been 
previously shown to correlate with the handgrip  test9, it reflects muscle mass rather than muscle strength or 
quality. Whether the combined use of creatinine/CysC ratio and handgrip test will improve the predictability of 
PPC occurrence in cardiac surgery patients needs further investigation. Second, the types of patients eligible for 
inclusion were limited. Given that chronic kidney disease critically affects fluid balance and is an important risk 
factor for  PPCs21,41, we tried to exclude its effect by limiting enrolments of such patients and by focusing only on 
the effect of creatinine/CysC ratio. In previous  studies5,32,33, however, the creatinine/CysC ratio was effective as 
an indicator in patients with stable chronic kidney disease, implying that in the future it could be widely applied 
in patients other than those with acute kidney injury. Third, because of the small AUROC and low specificity, 
our study can only be regarded as hypothesis-generating research. Since creatinine/CysC ratio is an objective and 
easily measurable parameter for screening in the pre-operative period, we expect further studies with sufficient 
power to appropriately examine the efficacy of the creatinine/CysC ratio.
In conclusion, in this retrospective analysis, a low creatinine/CysC ratio was associated with an increased 
risk of developing PPCs in older patients undergoing OPCAB.
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The datasets generated for this study are available on request to the corresponding author. The data are not 
publicly available due to privacy reasons.
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